High Net Worth Advisory Group’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$14K	–	704
2022 Q2	$14K	Hold	500	–	–	0.01%	496
2022 Q1	$27K	Hold	500	–	–	0.01%	414
2021 Q4	$29K	Buy	+500	New	+$29K	0.01%	411